Monoclonal Antibody Biosimilars

The first mAb biosimilars to be approved in Europe and elsewhere was the infliximab biosimilars (Inflectra and Remsima), which originator is Remicade. In October 2013, after the European Medicines Agency (EMA) gave a positive opinion for infliximab biosimilars, the European Commission granted a marketing authorization (MA) for these two biosimilars in the various therapeutic indications that are authorized for Remicade (i.e. indications in gastroenterology, rheumatology, and dermatology). As for previously approved biosimilars, the two aforementioned European institutions did not make a stand on the issues of substitution, and with good reason, as answering these questions does not fall within their areas of expertise and is the sole responsibility of EU Member States.

    Related Conference of Monoclonal Antibody Biosimilars

    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    August 06-07, 2024

    27th World Congress on Nursing, Pharmacology and Healthcare

    Aix-en-Provence, France
    August 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE
    March 13-14, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    April 14-15, 2025

    18th European Biosimilars Congress

    Aix-en-Provence, France

    Monoclonal Antibody Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in